A Locus on Chromosome 13 Influences Levels of TAFI Antigen in Healthy Mexican Americans

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Human Biology: The Official Publication of the American Association of Anthropological Genetics

• Publication date

  2006-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1353/hub.2006.0049PMID 17216805
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Roles of protease-activated receptors in a mouse model of endotoxemia.

  2006cited by this paper
• Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.

  2003cited by this paper
• Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)

  2003cited by this paper
• Acute Phase Mediators Modulate Thrombin-activable Fibrinolysis Inhibitor (TAFI) Gene Expression in HepG2 Cells*

  2003cited by this paper
• Vascular Development and Vessel Remodelling Association between TAFI antigen and Ala 147 Thr polymorphism of the TAFI gene and the angina pectoris incidence The PRIME Study

  2003cited by this paper
• Association between TAFI antigen and Ala147Thr polymorphism of the TAFI gene and the angina pectoris incidence

  2003cited by this paper
• Plasma Thrombin-Activatable Fibrinolysis Inhibitor Antigen Concentration and Genotype in Relation to Myocardial Infarction in the North and South of Europe

  2002cited by this paper
• Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state.

  2002cited by this paper
• Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Levels in Patients with Coronary Artery Disease Investigated by Angiography

  2002cited by this paper
• Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms

  2001cited by this paper
• Identification of polymorphisms in the 5'-untranslated region of the TAFI gene: relationship with plasma TAFI levels and risk of venous thrombosis.

  2001cited by this paper
• A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels.

  2001cited by this paper
• Association of a single nucleotide polymorphism in CPB2 encoding the thrombin‐activable fibrinolysis inhibitor (TAFI) with blood pressure

  2001cited by this paper
• Immunological Assay for the Determination of Procarboxypeptidase U Antigen Levels in Human Plasma

  2001cited by this paper
• Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled.

  2001cited by this paper
• Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.

  2000cited by this paper
• Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors

  2000cited by this paper
• Plasma Procarboxypeptidase U in Men with Symptomatic Coronary Artery Disease

  2000cited by this paper
• Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not1 2

  2000cited by this paper
• Plasma TAFI Antigen Variations in Healthy Subjects

  2000influential reference
• Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse,Whereas Carboxyeptidase N Is Not

  2000cited by this paper
• Characterization of the gene encoding human TAFI (thrombin-activable fibrinolysis inhibitor; plasma procarboxypeptidase B).

  1999cited by this paper
• Assay of procarboxypeptidase U, a novel determinant of the fibrinolytic cascade, in human plasma.

  1999cited by this paper
• Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B

  1999cited by this paper
• Multipoint quantitative-trait linkage analysis in general pedigrees.

  1998cited by this paper
• Plasma TAFI Levels Influence the Clot Lysis Time in Healthy Individuals in the Presence of an Intact Intrinsic Pathway of Coagulation

  1998cited by this paper
• A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor*

  1998cited by this paper
• TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex*

  1996cited by this paper
• The gene for human carboxypeptidase U (CPU)--a proposed novel regulator of plasminogen activation--maps to 13q14.11.

  1996cited by this paper
• Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor (*)

  1995cited by this paper
• Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen.

  1994cited by this paper
• Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent.

  1993cited by this paper
• The gene encoding human plasma carboxypeptidase B (CPB2) resides on chromosome 13.

  1992cited by this paper
• Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma.

  1991cited by this paper
• A novel , possibly functional , single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor ( TAFI ) gene is also associated with TAFI levels

  year unknowncited by this paper

• A Genome-wide Study of Common and Rare Genetic Variants Associated with Circulating Thrombin Activatable Fibrinolysis Inhibitor

  2018cites this paper
• Genetics of Cardiovascular Disease in Minority Populations

  2015cites this paper
• Association between genotype and plasma levels of thrombin-activated fibrinolysis inhibitor (TAFI) in the development of preeclampsia.

  2011cites this paper
• Genome scan of clot lysis time and its association with thrombosis in a protein C‐deficient kindred

  2011cites this paper
• analysis encoding thrombin-activatable fibrinolysis inhibitor: a functional Effect of single nucleotide polymorphisms on expression of the gene

  2010cites this paper
• The role of the fibrinolytic system in arterial and venous thrombosis

  2010cites this paper
• Deciphering the molecular basis of venous thromboembolism: where are we and where should we go?

  2010cites this paper
• TAFI: A Potential Target for Fibrinolytic Drugs

  2009cites this paper
• Effect of single nucleotide polymorphisms on expression of the gene encoding thrombin-activatable fibrinolysis inhibitor: a functional analysis.

  2008cites this paper
• A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels

  2008influential citation